In patients with COPD, there is much evidence that the serum levels of inflammatory mediators are increased, including tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6) or C reactive protein (CRP) [28,29]. The gene discussed is IL6; the disease is chronic obstructive pulmonary disease.